Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2008
12/03/2008CN101316837A Substituted pyrrolones as allosteric modulators of glucokinase
12/03/2008CN101316836A Substituted dihydroisoindolones as allosteric modulators of glucokinase
12/03/2008CN101316834A 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
12/03/2008CN101316823A 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents
12/03/2008CN101316815A Chemical process for the preparation of an amido-phenoxybenzoic acid compound
12/03/2008CN101314584A HGF/c-Met signalling channel restrainer, preparation method and application thereof
12/03/2008CN100439361C Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/03/2008CN100439360C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
12/03/2008CN100439359C Indolylmaleimide derivatives
12/03/2008CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents
12/03/2008CN100439326C Process for producing substituted aniline compound
12/02/2008US7459551 Method for preparing cyclic compounds
12/02/2008US7459475 less side effects; higher potency; chronic and neuropathic pain, epilepsy, manic depression, bipolar disorder, diabetic neuropathy; 3-[3-(2-Trifluoromethoxyphenyl)-phenyl]-1,2,4-triazole
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459471 Inclusion compound comprising cucurbituril derivatives as host molecule and pharmaceutical composition comprising the same
12/02/2008US7459465 Isoquinoline compound and pharmaceutical use thereof
12/02/2008US7459460 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/02/2008US7459456 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459414 Herbicides
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2359646C Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-.beta.-cyclodextrin or 2-hydroxypropyl-.beta.-cyclodextrin and method
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008144399A1 COMPLEXES COMPRISING α2-ADRENERGIC RECEPTOR AGONISTS AND COMPOSITIONS
11/27/2008WO2008144380A1 Hepatitis c virus inhibitors
11/27/2008WO2008144299A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders
11/27/2008WO2008143759A1 Pyrimidinones as casein kinase ii (ck2) modulators
11/27/2008WO2008143019A1 Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative
11/27/2008WO2008142550A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008WO2008142140A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/27/2008WO2008141731A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008046072A3 Chemical inducers of neurogenesis
11/27/2008US20080293942 Methods of Preparing 2-Imidazol-1-Yl-4-Methyl-6-Pyrrolidin-2-Yl-Pyrimidine and 4-(1-Alkylpyrrolidin-2-Yl)-2-(1H-Imidazol-1-Yl)-6-Methylpyrimidine Derivatives
11/27/2008US20080293940 Amide Derivative and Medicine
11/27/2008US20080293939 Quinazolinone derivatives useful as anti-hyperalgesic agents
11/27/2008US20080293936 Novel inhibitors of lysyl oxidase
11/27/2008US20080293778 Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
11/27/2008US20080293771 Azacyclylbenzamide derivatives as histamine-3 antagonists
11/27/2008US20080293763 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/27/2008US20080293749 Pyrrolidine(thi)ones Substituted by Heterocyclic Substituents in The 3-Position
11/27/2008US20080293743 (5S)-5-({[6-(2-cyclopropylpyrimidin-5-yl)-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; asthma, chronic obstructive pulmonary disease
11/27/2008US20080293733 Axl kinase inhibitors
11/27/2008US20080293730 Tricyclo Substituted Amides
11/27/2008US20080293728 Complexes Comprising alpha2-Adrenergic Receptor Agonists and Compositions
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293719 Pyridiazinone Derivatives for the Treatment of Tumours
11/27/2008US20080293715 Therapeutic Pyrazolo[3,4-b]Pyridines and Indazoles
11/27/2008US20080293708 Pyrimidine Derivatives
11/27/2008US20080293699 Inhibitors of thapsigargin-induced cell death
11/27/2008US20080293688 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008CA2687975A1 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation
11/27/2008CA2687944A1 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
11/27/2008CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors
11/27/2008CA2685318A1 5-(aminoazacyclyl)-3-sulfonyl-1h-indazoles as 5-hydroxytryptamine-6 ligands for the treatment of cns disorders
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1994032A1 Pyrazole derivatives as sigma receptor inhibitors
11/26/2008EP1994030A1 Multi-cyclic compounds and method of use
11/26/2008EP1994027A2 N-formyl hydroxylamine compounds
11/26/2008EP1994022A2 N-substituted-azacyclylamines as histamine-3 antagonists
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1994011A1 Sulfonyl benzimidazole derivatives
11/26/2008EP1994000A2 Water-soluble cc-1065 analogs and their conjugates
11/26/2008EP1993994A2 Deuterated hepatitis c protease inhibitors
11/26/2008EP1993554A2 Urotensin ii receptor antagonists
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1603913B1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008CN101313223A Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-l-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group
11/26/2008CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
11/26/2008CN101312726A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312725A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436451C Novel process for producing ramosetron or its salt
11/26/2008CN100436450C Novel triarylimidazoles
11/26/2008CN100436427C Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors
11/26/2008CN100436425C Fused imidazolium derivatives
11/26/2008CN100436414C Azabicyclo derivatives as muscarinic receptor antagonists
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456280 Maleimide resin with cyanurate core
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008US7456201 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility
11/25/2008US7456196 Alzheimer's disease; antihistamine; attention deficit disorder; hyperactivity; bipolar disorder; cognition activators; psychological disorder; anticancer agent; antidepressants; antiepileptic agents; gastrointestinal disorder; analgesics; 6-{2-[(2R)-2-methyl-1-pyrrolidinyl]ethyl}-2-(3-pyridinyl)quinoline
11/25/2008US7456190 autoimmune disease; antiinflammatory agents; bone disorders; central nervous system disorders; cardiovascular disorders; Alzheimer's disease; antihistamines; antiallergens
11/25/2008US7456184 Agonist or antgonist and binders and inversion of agonist
11/25/2008US7456183 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide
11/25/2008US7456182 Phenylpiperazines
11/25/2008US7456180 Piperazine derivatives and their use as therapeutic agents
11/25/2008US7456176 Benzotriazine inhibitors of kinases
11/25/2008US7456169 Heterocyclic kinase inhibitors
11/25/2008US7456164 Useful for treatment of H3-related diseases such as neurologic disorders, or inflammatory, respiratory and allergic diseases, disorders and conditions; for example, 4-[4-(1-isopropylpiperidin-4-yloxy)phenyl]tetrahydropyran-4-carbonitrile; well absorbed from gastrointestinal tract, metabolically stable
1 ... 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 ... 626